Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

Nature

Volumn 457, Issue 7226, 2009, Pages 200-204

  Rebouissou, Sandra ^a,b   Amessou, Mohamed ^a,b   Couchy, Gabrielle ^a,b   Poussin, Karine ^a,b   Imbeaud, Sandrine ^c,d   Pilati, Camilla ^a,b   Izard, Tina ^e   Balabaud, Charles ^f,g   Bioulac Sage, Paulette ^f,h   Zucman Rossi, Jessica ^a,b  

^a Université Paris 13   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f INSERM   (France)

^g HÔPITAL SAINT ANDRÉ   (France)

^h HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; STAT3 PROTEIN;

GENETIC ANALYSIS; IMMUNE SYSTEM; LIGAND; MOLECULAR ANALYSIS; MUTATION; PROTEIN; TUMOR;

ARTICLE; BINDING SITE; EPITHELIUM TUMOR; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY INFILTRATE; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADENOMA, LIVER CELL; CELL LINE, TUMOR; CYTOKINE RECEPTOR GP130; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INTERFERONS; INTERLEUKIN-6; SEQUENCE DELETION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 58149326854     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07475     Document Type: Article

References (34)

1. Bioulac-Sage, P. et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46, 740-748 (2007).
2. Zucman-Rossi, J. et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43, 515-524 (2006).
3. Grivennikov, S. & Karin, M. Autocrine IL-6 signaling: a key event in tumourigenesis? Cancer Cell 13, 7-9 (2008).
4. Akira, S. et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71 (1994).
5. Wegenka, U. M., Buschmann, J., Lutticken, C., Heinrich, P. C. & Horn, F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13, 276-288 (1993).
6. Hibi, M. et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157 (1990).
7. Boulanger, M. J., Chow, D. C., Brevnova, E. E. & Garcia, K. C. Hexameric structure and assembly of the interleukin-6/IL-6α-receptor/gp130 complex. Science 300, 2101-2104 (2003).
8. Ward, L. D. et al. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J. Biol. Chem. 269, 23286-23289 (1994).
9. Lutticken, C. et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263, 89-92 (1994).
10. Murakami, M. et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260, 1808-1810 (1993).
11. Stahl, N. et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components. Science 263, 92-95 (1994).
12. Coulouarn, C. et al. Genome-wide response of the human Hep3B hepatoma cell to proinflammatory cytokines, from transcription to translation. Hepatology 42, 946-955 (2005).
13. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254 (1995).
14. Chow, D., He, X., Snow, A. L., Rose-John, S. & Garcia, K. C. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291, 2150-2155 (2001).
15. Skiniotis, G., Boulanger, M. J., Garcia, K. C. & Walz, T. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nature Struct. Mol. Biol. 12, 545-551 (2005).
16. Li, H. & Nicholas, J. Identification of amino acid residues of gp130 signal transducer and gp80α receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6. J. Virol. 76, 5627-5636 (2002).
17. Ernst, M. et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumourigenesis in gp130 receptor mutant mice. J. Clin. Invest. 118, 1727-1738 (2008).
18. Maione, D. et al. Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J. 17, 5588-5597 (1998).
19. Judd, L. M. et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126, 196-207 (2004).
20. Judd, L. M. et al. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumourigenesis. Gastroenterology 131, 1073-1085 (2006).
21. Tebbutt, N. C. et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nature Med. 8, 1089-1097 (2002).
22. Boulton, T. G., Stahl, N. & Yancopoulos, G. D. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 269, 11648-11655 (1994).
23. Croker, B. A. et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nature Immunol. 4, 540-545 (2003).
24. Bioulac-Sage, P. et al. Clinical, morphologic, and molecular features defining socalled telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128, 1211-1218 (2005).
25. Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409-426 (2003).
26. Bluteau, O. et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nature Genet. 32, 312-315 (2002).
27. Chen, Y. W., Jeng, Y. M., Yeh, S. H. & Chen, P. J. P53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 36, 927-935 (2002).
28. Boyault, S. et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45, 42-52 (2007).
29. Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124 (2007).
30. Rebouissou, S. et al. HNF1α inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J. Biol. Chem. 282, 14437-14446 (2007).
31. Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315 (2004).
32. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
33. Li, C. & Hung Wong, W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2, Research0032 (2001).
34. Irizarry, R. A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).